Meta tags:
description=;

Headings (most frequently used words):

the, cell, and, gene, therapy, industry, work, discover, our, advancing, through, powerful, collaborations, how, we, with, you, capabilities, impact, that, has, on, uk,

Text of the page (most frequently used words):
and (26), the (23), cell (16), our (16), gene (12), therapies (12), #therapy (9), 2026 (7), with (7), innovation (5), work (5), are (5), you (5), atmps (4), clinical (4), regulatory (4), manufacturing (4), sector (4), discover (4), catapult (4), september (4), industry (4), contact (3), policy (3), automation (3), more (3), impact (3), cgt (3), through (3), growth (3), this (3), can (3), for (3), that (3), 2012 (3), since (3), your (3), skills (2), training (2), facilitating (2), nhs (2), adoption (2), integrated (2), non (2), market (2), access (2), strategy (2), supporting (2), spin (2), outs (2), start (2), ups (2), investment (2), digital (2), capabilities (2), events (2), news (2), resources (2), how (2), team (2), round (2), project (2), annual (2), review (2), research (2), advanced (2), view (2), latest (2), therapeutics (2), support (2), which (2), important (2), term (2), compared (2), 2018 (2), atmp (2), companies (2), help (2), from (2), advancing (2), powerful (2), collaborations (2), cookie, accessibility, privacy, terms, conditions, feedback, legal, careers, facilities, tools, meet, about, august, 2nd, spotlight, enhancing, dna, impurity, detection, aav, picogreen, assay, 8th, sets, out, opportunity, convert, strength, into, 30th, 5th, october, all, achilles, thrilled, part, consortium, continued, processes, pioneer, field, personalised, excited, lend, expertise, believe, deliver, significant, benefits, patients, technologies, collaboration, meeting, needs, fast, moving, worked, closely, four, customers, early, adopter, program, pilot, new, quantum, flex, platform, quell, agreement, strategic, step, gives, flexibility, scale, production, capacity, crucial, success, business, both, near, prepare, first, trial, qel, 001, longer, advance, pipeline, novel, engineered, treg, neuroinflammatory, autoimmune, diseases, 540, 000, jobs, active, trials, 178, increase, cleanroom, footprint, 111, received, read, case, studies, mandate, catalyse, facilitate, inception, have, been, gathering, qualitative, quantitative, data, showcase, having, researchers, general, has, will, accelerate, projects, helping, safer, effective, scalable, affordable, make, job, forefront, innovations, ready, whenever, might, need, benefit, unique, infrastructure, specialists, across, life, cycle, who, collaborate, find, solutions, challenges, brochure, whether, working, looking, manufacture, require, commercialisation, medicinal, products,

Text of the page (random words):
advancing cell and gene therapies through powerful collaborations cell and gene therapy advancing the cell and gene therapy industry through powerful collaborations whether you are working in research looking to manufacture therapies or require support in the commercialisation of advanced therapy medicinal products atmps we can help view our brochure 2026 cell and gene therapy catapult annual review discover more how we work with you benefit from our unique infrastructure and a team of specialists from across the cell and gene therapy life cycle who can collaborate with you to find solutions to your atmp challenges contact us discover our capabilities we will work with you to accelerate your projects helping your cell and gene therapies to be safer more effective scalable and affordable we make it our job to be at the forefront of the latest innovations in cell and gene therapies so that we are ready to help whenever you might need us cell therapies gene therapies automation digital innovation supporting spin outs start ups and sector investment manufacturing innovation integrated non clinical regulatory and market access strategy facilitating nhs adoption of atmps skills and training discover the impact that our work has on the uk cell and gene therapy industry it is our mandate to catalyse and facilitate growth in the cell and gene therapy industry since our inception in 2012 we have been gathering qualitative and quantitative data to showcase the impact we are having on the companies and researchers we work with and on general industry growth read our case studies 5 5b received by atmp companies in the uk since 2012 111 increase in cleanroom footprint for manufacturing atmps in the uk since 2018 178 active clinical trials compared to 85 in 2018 7 000 jobs in the sector in the uk compared to 540 in 2012 our agreement with cgt catapult is an important strategic step that gives us the flexibility to scale our production capacity which is crucial to the success of our business both near term as we prepare for our first clinical trial with qel 001 and longer term as we advance our pipeline of novel engineered treg cell therapies in neuroinflammatory and autoimmune diseases quell therapeutics collaboration is important in meeting the needs of this fast moving sector we worked closely with four customers in our early adopter program to pilot the new quantum flex platform cell therapy technologies we are thrilled to be part of this consortium to support the continued innovation of cell therapy manufacturing processes as a pioneer in the field of personalised cell therapies we are excited to lend our expertise to this project which we believe can deliver significant benefits for patients achilles therapeutics latest news events resources view all 5th october 2026 regulatory round up september 2026 30th september 2026 cgt catapult annual review sets out the uk s opportunity to convert research strength in advanced therapies into growth 8th september 2026 r d project spotlight enhancing dna impurity detection in aav through automation of the picogreen assay 2nd september 2026 regulatory round up august 2026 discover cgt catapult about us cell and gene therapies meet the team our impact how we work resources and tools more news events facilities careers contact legal feedback capabilities cell therapies gene therapies automation digital innovation supporting spin outs start ups and sector investment manufacturing innovation integrated non clinical regulatory and market access strategy facilitating nhs adoption of atmps skills and training terms and conditions privacy policy accessibility policy cookie policy contact